
Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Medicines for Malaria Venture (MMV) has established a new collaboration with S Kant HEALTHCARE Ltd…
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…